Changxin Technology’s Fifth-Gen Platform Kicks Off Mass Production; Lijian-1 Rocket Orders Stretch into 2H 2027
5 day ago / Read about 0 minute
Author:小编   

During a press conference hosted by the State Council Information Office, it was announced that, as part of the “15th Five-Year Plan,” the National Medical Products Administration will roll out a series of initiatives to foster the growth of innovative drugs and medical devices. In terms of industry advancements, the Pengcheng Shoufa Star and Pengcheng SUSTech No.1 satellites were successfully launched into orbit, marking several technological leaps and paving the way for 6G technology development. The Lijian-1 Yao-18 carrier rocket was also successfully launched, boasting a robust order book and an annual production capacity of 30 launches, thereby disrupting the traditional mold of private carrier rocket manufacturing. Changxin Technology’s fifth-generation technology platform has entered mass production, witnessing a more than 50% surge in single-wafer output, with its products now integrated into leading domestic smartphones. Furthermore, a number of companies, such as Zijian Electronic and Affa Medical, have made announcements concerning shareholder reductions.